EMPLOYMENT AGREEMENTEmployment Agreement • September 26th, 2011 • Galena Biopharma, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement is made and entered into by and between RNCS, Inc. (the “Company”), a Delaware corporation with its principal place of business at Worcester, Massachusetts, and Pamela Pavco, of Longmont, Colorado (the “Executive”), signed on September 24, 2011 and effective as of the Effective Date, as defined in that certain Securities Purchase Agreement, by and among Tang Capital Partners, LP, RTW Investments, LLC, the Company, and RXi Pharmaceuticals Corporation (the “Securities Purchase Agreement”), and entered into as of September 24, 2011 (the “Effective Date”).
CONTRIBUTION AGREEMENTContribution Agreement • September 26th, 2011 • Galena Biopharma, Inc. • Pharmaceutical preparations • California
THIS CONTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of September 23, 2011 (the “Effective Date”), by and between RXi Pharmaceuticals Corporation, a Delaware corporation (“RXi”) and RNCS, Inc., a Delaware corporation and wholly owned subsidiary of RXi (“RNCS”).
INVESTOR SUBSCRIPTION AGREEMENTInvestor Subscription Agreement • September 26th, 2011 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
This Investor Subscription Agreement (this “Agreement”) is entered into as of September 24, 2011 by and between RXi Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and the purchasers identified on the signature page hereto (each a “Purchaser” and together, the “Purchasers”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • September 26th, 2011 • Galena Biopharma, Inc. • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (this “Amendment”) is made as of September 23, 2011, by and between RXi Pharmaceuticals Corporation, a Delaware corporation (“Employer”), and Mark W. Schwartz, Ph.D., an individual and resident of the State of California (“Employee”), with reference to the following facts:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 26th, 2011 • Galena Biopharma, Inc. • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (as amended, modified or supplemented from time to time, this “Agreement”) is made and entered into as of September 24, 2011 (the “Effective Date”) by and among Tang Capital Partners, LP, a Delaware limited partnership (“Tang”), RTW Investments, LLC, a Delaware limited liability company (“RTW” and, together with Tang, the “Investors”), RNCS, Inc., a Delaware corporation (the “Company”), and RXi Pharmaceuticals Corporation, a Delaware corporation (“RXi”).
